Plasma Homocysteine Concentrations in Young Individuals at Increased Risk of Type 2 Diabetes are Associated with Subtle Differences in Glomerular Filtration Rate but Not with Insulin Resistance

S. A. Schäfer; K. Müssig; N. Stefan; H.-U. Häring; A. Fritsche; B. M. Balletshofer

doi:10.1055/s-2006-924073

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2006; 114(6): 306-309
DOI: 10.1055/s-2006-924073

Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Plasma Homocysteine Concentrations in Young Individuals at Increased Risk of Type 2 Diabetes are Associated with Subtle Differences in Glomerular Filtration Rate but Not with Insulin Resistance

S. A. Schäfer[*] ¹ , K. Müssig[*] ¹ , N. Stefan¹ , H.-U. Häring¹ , A. Fritsche¹ , B. M. Balletshofer¹

¹Department of Endocrinology, Diabetology, Nephrology, Angiology, and Clinical Chemistry, University Hospital of Internal Medicine, University of Tübingen, Tübingen, Germany

Abstract

Full Text

References

1 Abbasi F, Facchini F, Humphreys M H, Reaven G M. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis. 1999; 146 175-178
2 Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis. 1993; 103 149-157
3 Bostom A G, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997; 52 10-20
4 Buysschaert M, Dramais A S, Wallemacq P E, Hermans M P. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000; 23 1816-1822
5 Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba E, Inaba M, Okuno Y, Nishizawa Y. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 2001; 24 533-538
6 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20 1183-1197
7 Fonseca V, Guba S C, Fink L M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev. 1999; 20 738-759
8 Fonseca V, Dicker-Brown A, Ranganathan S, Song W, Barnard R J, Fink L, Kern P A. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism. 2000; 49 736-741
9 Fonseca V A, Fink L M, Kern P A. Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis. 2003; 167 105-109
10 Giltay E J, Hoogeveen E K, Elbers J M, Gooren L J, Asscheman H, Stehouwer C D. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis. 1998; 139 197-198
11 Godsland I F, Rosankiewicz J R, Proudler A J, Johnston D G. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab. 2001; 86 719-723
12 Hofmann M A, Kohl B, Zumbach M S, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt A M, Fiehn W, Ziegler R, Wahl P, Nawroth P P. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care. 1998; 21 841-848
13 Hoogeveen E K, Kostense P J, Jakobs C, Dekker J M, Nijpels G, Heine R J, Bouter L M, Stehouwer C D. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation. 2000; 101 1506-1511
14 Hultberg B, Agardh E, Andersson A, Brattstrom L, Isaksson A, Israelsson B, Agardh C D. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest. 1991; 51 277-282
15 Kark J D, Selhub J, Bostom A, Adler B, Rosenberg I H. Plasma homocysteine and all-cause mortality in diabetes. Lancet. 1999; 353 1936-1937
16 Levey A S, Greene T, Kusek J W, Beck G J. MDRD Study Group . A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol. 2000; 11 A0828
17 Manjunath G, Sarnak M J, Levey A S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001; 10 785-792
18 Matsuda M, DeFronzo R A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22 1462-1470
19 Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987; 30 123-131
20 Reaven G M. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?. Diabetes Care. 1984; 7 17-24
21 Veldman B A, Verboort G, Blom H, Smits P. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance. Diabetic Medicine. 2005; 22 301-305

1 * These authors contributed equally to this article.

M.D. Bernd M. Balletshofer

Medizinische Klinik IV
Universitätsklinikum Tübingen

Otfried-Müller-Straße 10

72076 Tübingen

Germany

Phone: + 49-(0)7071-29 83 670

Fax: + 49-(0)7071-29 44 54

Email: bernd.balletshofer@med.uni-tuebingen.de